饮食糖和含糖饮料摄入增加炎症性肠病风险:系统性审查和元分析
Isha Maniyar1, Arpita Jajoo2, Gala Godoy Brewer3
1Department of Medicine, UCSF School of Medicine, San Francisco, California, USA.
United European gastroenterology journal
|June 18, 2025
概括
高糖摄入量,包括添加糖和含糖饮料,与患炎症性肠病 (IBD) 的风险更高有关. 减少糖的消费可能有助于降低IBD的风险,如克罗恩氏病和性结肠炎.
科学领域:
- 胃肠病学 胃肠病学
- 营养科学 营养科学
- 流行病学 流行病学
背景情况:
- 饮食糖消费与炎症性肠病 (IBD) 风险之间的关系尚不清楚.
- 之前的研究已经产生了关于糖摄入量和IBD发展的不一致的结果.
研究的目的:
- 系统地审查和元分析最近关于糖消费与IBD发展风险之间的关联的数据.
- 澄清添加糖和含糖饮料对IBD风险的具体影响.
主要方法:
- 在多个数据库 (PubMed,EMBASE,CINAHL,Cochrane Central,Web of Science,Scopus) 中进行了全面的文献搜索.
- 两个独立审查员选了45项选定的研究 (11项前性,34项后性) 的资格.
- 随机效应模型被用来进行元分析和估计赔率比率.
主要成果:
- 添加糖摄入量与克罗恩病 (OR 1.66) 和性结肠炎 (OR 1.59) 的风险增加有显著关联.
- 苏打水和其他含糖饮料的摄入量也与克罗恩病 (OR 1.58) 和性结肠炎 (OR 1.72) 的风险增加有显著关联.
- 聚合分析包括超过50万和70万个人的数据,分别是添加糖和饮料摄入量.
结论:
- 添加糖和含糖饮料的饮食摄入量与患克罗恩病和性结肠炎的风险更高有关.
- 研究结果表明,减少糖类消费可能是减轻IBD风险的潜在策略.
- 建议进行进一步的前性研究,以巩固这些关联.
关键词:
克罗恩氏病 克罗恩氏病是什么?添加糖是指添加的糖.炎症性肠病是一种炎症性肠病.这是一个元分析.苏打水是一种苏打水.软饮料 软饮料 软饮料糖的摄入量 糖的摄入量含糖甜饮料的饮料.含糖的饮料 含糖的饮料性结肠炎是一种更多相关视频
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
345
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
345
01:30Inflammatory Bowel Disease II: Crohn's Disease
401
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
401
01:17Irritable Bowel Syndrome I: Introduction
402
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
402
01:29Inflammatory Bowel Disease IV: Pharmacological Management
204
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
204
01:17Chronic Bowel Disorders: Introduction
543
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
543